Hypertrophic cardiomyopathy classification: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 3: Line 3:
'''Editors-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org]
'''Editors-In-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:mgibson@perfuse.org]
==Overview==
==Overview==
There are two variants of hypertrophic cardiomyopathy: an obstructive variant, and a non-obstructive  variant. A non-obstructive variant of HCM is known as apical hypertrophic cardiomyopathy <ref name="Rivera-Diaz, Moosvi 1996">Rivera-Diaz J, Moosvi AR. Apical hypertrophic cardiomyopathy. ''South Med J''. 1996 Jul; '''89'''(7):711-3. ([http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=8685759 Medline abstract]; [http://www.sma.org/smj/96jul12.htm Full text])</ref>,which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent).


==References==
==References==

Revision as of 23:39, 7 August 2011

Hypertrophic Cardiomyopathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hypertrophic Cardiomyopathy from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hypertrophic cardiomyopathy classification On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hypertrophic cardiomyopathy classification

CDC on Hypertrophic cardiomyopathy classification

Hypertrophic cardiomyopathy classification in the news

Blogs on Hypertrophic cardiomyopathy classification

Directions to Hospitals Treating Hypertrophic cardiomyopathy

Risk calculators and risk factors for Hypertrophic cardiomyopathy classification

Editors-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

There are two variants of hypertrophic cardiomyopathy: an obstructive variant, and a non-obstructive variant. A non-obstructive variant of HCM is known as apical hypertrophic cardiomyopathy [1],which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent).

References

  1. Rivera-Diaz J, Moosvi AR. Apical hypertrophic cardiomyopathy. South Med J. 1996 Jul; 89(7):711-3. (Medline abstract; Full text)